CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 165 enrolled
Drug / intervention
esomeprazoledrug
Likely dose
esomeprazole 20 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01138969
NCT01138969Phase 2Completed
CompareCT.gov

Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer and Gastrointestinal Bleeding

Kaohsiung Veterans General Hospital.·interventional·Posted Jun 8, 2010·Updated Sep 9, 2015

In Brief

A Phase 2 clinical trial evaluating esomeprazole for Peptic Ulcer. Completed, enrolled 165 participants across 1 site.

Detailed Summary

Proton Pump Inhibitors (PPI) can prevent the recurrence of peptic ulcer in clopidogrel users.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeptic Ulcer
CountriesTaiwan
Collaborators--

Timeline

Phase 2CompletedFinished
2009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 8, 2010
Enrollment StartAug 1, 2008
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 16.1 years ago

Interventions

esomeprazoledrug

esomeprazole 20 mg qd for 6 months